Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7 Genitourinary 5 Thoracic 4 Other hematologic neoplasm 3 Lymphoid 3 Breast 3 Gynecologic 2 Dermatologic 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Head & Neck 1 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 1435 Fluorouracil 1316 Capecitabine 1112 Gemcitabine 1054 Leucovorin 935 Bevacizumab 845 Irinotecan 827 Cisplatin 673 Radiotherapy 559 Cetuximab 481 pembrolizumab 435 Paclitaxel 400 Drug Therapy 358 Nivolumab 349 130-nm albumin-bound paclitaxel 326 Docetaxel 289 Sorafenib 288 S 1 (combination) 278 Folfox protocol 266 Albumin-Bound Paclitaxel 263 Surgical Procedures, Operative 256 lenvatinib 222 sintilimab 218 tislelizumab 213 durvalumab 211 regorafenib 208 Radiosurgery 204 Magnetic Resonance Spectroscopy 203 apatinib 202 Neoadjuvant Therapy 190

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Valacyclovir × Gastrointestinal × Clear all

NCT00638612 2023-08-25

PaTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡